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NFATc1 self-promotes to build bone
 
Self-promotion is the way to get ahead during bone development, according to 
Asagiri and colleagues. They show on page 1261 that the inducible transcription factor 
NFATc1 must turn on its own expression for bone-resorbing osteoclasts to form.
NFATc1 drives osteoclast-specific gene expression and is essential for the 
development of these cells in vitro. But whether NFATc1 is required in vivo was 
unknown, as deletion of the NFATc1 gene is lethal in mice. Another open 
questions was whether NFATc2—NFATc1’s closest relative—can drive osteoclast 
formation in the absence of NFATc1.
Asagiri and colleagues now show that NFATc1 is indeed essential for osteoclast 
formation in vivo, as only NFATc1-expressing stem cells rescued osteoclast 
development when transferred into osteoclast-deficient mice. NFATc1-deficient 
stem cells failed at this task, despite having normal expression of NFATc2.
Transcriptional regulation explained why only NFATc1 could do the job. 
Stimulation of bone marrow cells with the osteoclast growth factor RANKL 
(receptor activator of NF-
 
 
 
B ligand) caused the NFATc2 protein in the cell—
along with RANKL-induced NF-
 
 
 
B proteins—to pile onto the NFATc1 promoter 
at the expense of the NFATc2 promoter. This binding induced the expression of 
NFATc1, which then bound back to its own promoter, thus amplifying NFATc1 
production. The NFATc1 promoter also hoarded histone acetylases, whose DNA 
modifications facilitate transcription. The authors are now analyzing the 
chromatin structure of the two promoters, which might help explain why these 
proteins avoid the NFATc2 promoter. 
NFATc1-deficient mice (right) lack osteoclasts and thus have abnormally dense bones.
 
Worming away from allergies
 
Worms in the gut keep allergies at bay, say Wilson and colleagues on page 1199. Parasitic 
helminth infections, they show, activate regulatory T (T reg) cells in the gut. These T reg cells are 
then dispatched to the lungs, where they dampen the immune response to inhaled allergens.
Parasitic worm infections, common among children in tropical and subtropical regions, are 
associated with decreased responsiveness to allergens. The hygiene hypothesis, which posits that 
decreased childhood exposure to T helper (Th) 1–inducing microbes (such as bacteria and viruses) 
increases the risk of developing Th2-driven allergies later in life, might explain this observation. 
But the allergy-soothing effect of worm infections is unlikely to be due to Th1–Th2 antagonism, 
as both helminth infections and allergies induce potent Th2 responses.
Wilson and colleagues now show that mice infected with an intestinal helminth had decreased 
airway inflammation and Th2 effector cytokine production in response to inhaled allergens, as 
compared with uninfected mice. T reg cells developed in response to the worm infection—possibly 
a tactic developed by the parasite to avoid immune expulsion. These cells were the culprits behind 
the worm-induced allergy suppression, as uninfected mice given T reg cells from infected mice 
were rendered similarly allergy-resistant.
The authors are now investigating how chronic worm infections trigger T reg cell responses. 
In the meantime, the hygiene hypothesis may need refinement, as increased allergic responses 
might result more from a paucity of T reg cells than from diminished Th1 responses. 
Allergic airway inflammation 
(purple) is decreased in worm-
infected mice (bottom).
 
NKT cells get specialized
 
A report on page 1279 suggests that, for anti-
tumor immunity, all natural killer T (NKT) cells
are not created equal. Crowe and colleagues
show that a subset of liver-derived NKT cells is
uniquely equipped to fight off tumors.
NKT cells are innate immune cells known
for their rapid production of both T helper (Th)
1 and Th2 cytokines upon stimulation. NKT
cells can either promote or suppress immune re-
sponses, likely depending upon which cytokines
the cells predominantly produce. Subsets of
NKT cells have been identified (based on the
expression of CD4) that have distinct cytokine
production profiles in vitro. But whether these
subsets are functionally distinct in vivo had not
been tested.
In their previous work, this group had
shown that NKT cells from the liver were able
to combat tumors in mice. They now show that
it is only CD4
 
 
 
 NKT cells from the liver than
can promote tumor rejection. CD4
 
 
 
 NKT cells
from the liver and both CD4
 
 
 
 and CD4
 
 
 
 NKT
cells derived from the spleen or thymus were ill
equipped for the job.
The authors are now trying to determine
what sets the CD4
 
 
 
 liver NKT cells apart from
the rest, as cytokine production among the
NKT cell subsets was comparable. In the mean-
time, the identification of a specialized anti-
tumor subset of NKT cells may provide a way to
improve upon current NKT cell–based tumor
therapies. 
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Crk gets hijacked
 
The ulcer-inducing bacterium 
 
Helicobacter
pylori
 
 busts through the cells that line the
stomach by hijacking a host protein,
suggest Suzuki and colleagues on page
1235. The co-opted protein turns on
multiple signaling pathways in gastric
cells that cause the normally adhesive
cells to pull apart from their neighbors.
Roughly half of all people worldwide
have 
 
H. pylori
 
 living in their stomachs.
Most people host the infection without
consequence but, in some, 
 
H. pylori
 
 in-
fection triggers peptic ulcers and gastric
cancer. 
 
H. pylori
 
 encodes a set of proteins
that allows it to adhere to and thrive in
the stomach and to avoid immune attack.
One of these proteins—CagA (cyto-
toxin-associated antigen-A)—helps ward
off immune cells but also disrupts the
epithelial cells that line the stomach.
Many studies have investigated how
CagA, which is injected into gastric epi-
thelial cells through a specialized bacterial
 
Gassy degeneration
 
Nitric oxide (NO) gas spurs on brain degeneration, according to a study 
on page 1163. Nathan and colleagues show that the NO-producing 
enzyme iNOS accelerates brain destruction and death in a mouse 
model of Alzheimer’s disease.
Alzheimer’s disease is a lethal neurodegenerative disease that causes 
progressive memory loss and dementia. The disease is associated with a 
build-up in the brain of peptide fragments derived from a protein called 
 
 
 
-amyloid precursor protein (APP). APP is a protein that normally gets 
cleaved in the brain, although the functions of APP and of its primary 
cleavage products are poorly understood.
Mutations in APP, or in the enzymes that chop it up, result in the 
overproduction of the disease-causing peptide (known as A
 
 
 
). Although it is 
iNOS promotes the accumulation of A  peptide (brown) in 
the brain.
 
not completely clear how A
 
 
 
 contributes to disease, it has been shown to trigger iNOS expression in brain cells. This 
NO-producing enzyme is normally triggered by immune responses and inflammation and is needed to fight off 
certain infections. But in the brain, iNOS may contribute to mitochondrial and protein damage that destroys neurons.
This group and others found iNOS in brain lesions of patients with Alzheimer’s disease, but no studies 
had investigated whether iNOS contributed to disease progression. Nathan and colleagues now show that 
Alzheimer’s-prone mice that lack iNOS live twice as long and develop fewer amyloid plaques than iNOS-
expressing mice. Both groups of mice developed some plaques initially, but the iNOS-deficient mice were 
spared the rapid accumulation of plaques later in life.
The delayed effect of the iNOS deficiency was likely due to a positive feedback loop between the enzyme and 
the A
 
 
 
 peptide, suggests Nathan. A
 
 
 
 might have to accumulate before it triggers the production of iNOS. iNOS 
then exacerbates A
 
 
 
 accumulation, perhaps in part by blocking proteasomal degradation, a pathway the cell uses 
to dispose of A
 
 
 
. When this loop is interrupted, disease progression is slowed. The group now plans to test iNOS 
inhibitors in Alzheimer’s-prone mice to see if a pharmacological approach recapitulates the genetic approach.
Based on these results, Nathan suggests that iNOS inhibitors—which have already been produced and tested in 
humans—might be a promising and thus far overlooked therapy for the treatment of this devastating disease. 
 
secretion system, helps breach the epi-
thelial lining of the stomach. Once inside
the cells, CagA binds to a variety of intra-
cellular signaling proteins. But it was not
clear which of these proteins is required
for CagA-induced cell scattering.
Suzuki and colleagues now identify a
new target of CagA: the Crk family of
adaptor proteins. CagA–Crk binding in
infected epithelial cells triggered the
activation of downstream signaling
pathways, including the Ras–Raf and
Rac1–WAVE pathways, which are nor-
mally induced during routine cell turn-
over. These signals prompted the expulsion
of adhesive proteins 
 
 
 
-catenin and E-cad-
herin from the adherens junctions that
hold the cells together.
The liberation of 
 
 
 
-catenin  from
adherens junctions not only compromises
cell contacts, but likely also induces
aberrant proliferation of the cells, as
nuclear 
 
 
 
-catenin drives the expression
of cell cycle–promoting genes such as
cyclin D1. Both cell scattering and pro-
liferation compromise the integrity of
the stomach lining, thus contributing to
the development of 
 
H. pylori
 
–induced
gastric disease. 
The H. pylori CagA protein disrupts cell–cell 
contacts among normally adherent 
epithelial cells.
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